article thumbnail

Shorten the Blanking Period After Atrial Fibrillation Ablation, Experts Say

DAIC

Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrial fibrillation ablation, Musat et al. ERAT is often attributed to transient inflammation induced by tissue damage during ablation and short-term imbalances in autonomic innervation.

article thumbnail

News from EHRA 2024: International Experts Agree on Standards for Catheter Ablation of Atrial Fibrillation

DAIC

An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.

article thumbnail

Comparison of Anticoagulation With Left Atrial Appendage Closure After Atrial Fibrillation Ablation

American College of Cardiology

The goal of the OPTION trial was to evaluate left atrial appendage closure compared with anticoagulation among patients who underwent catheter-based atrial fibrillation (AF) ablation.

article thumbnail

Association between triglyceride–glucose index trajectories and radiofrequency ablation outcomes in patients with stage 3D atrial fibrillation

Cardiovascular Diabetology

This study investigates the relationship between triglyceride-glucose (TyG) index trajectories and the results of ablation in patients with stage 3D atrial fibrillation (AF).

article thumbnail

Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction

JAMA Cardiology

This systematic review and meta-analysis investigates the efficacy of catheter ablation compared with rate or rhythm control among patients with atrial fibrillation and heart failure.

article thumbnail

Long-term Health-related Quality of Life and Rhythm-Outcomes of Catheter Ablation versus Antiarrhythmic Drugs in Patients with Atrial Fibrillation.

HeartRhythm

Data on long-term effects of catheter ablation versus antiarrhythmic drugs (AAD) on health-related quality of life (HRQoL) and atrial fibrillation (AF) burden are limited.

article thumbnail

Catheter ablation in patients with atrial fibrillation and dilated cardiomyopathy

Frontiers in Cardiovascular Medicine

Introduction Catheter ablation is an effective and safe strategy for treating atrial fibrillation patients. Nevertheless, studies on the long-term outcomes of catheter ablation in patients with dilated cardiomyopathy are limited. Among the catheter ablation group, 58.7% ( n  = 27) had persistent atrial fibrillation.